GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
City of Hope Medical Center
Roswell Park Cancer Institute
Virginia Commonwealth University
University of California, San Francisco
University College, London
University of Maryland, Baltimore
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Rochester
National Institutes of Health Clinical Center (CC)
Mesoblast, Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center